Postoperative client with sleep apnea on opioids: snoring, sedation and first actions

Why this client is at higher risk

Obstructive sleep apnea means the upper airway repeatedly collapses during sleep. Anaesthesia and sedation increase the risk of obstruction, which is why known OSA should be shared with the anaesthetic team and CPAP used around surgery. After surgery, opioid analgesia adds a second problem: opioids can slow breathing and reduce ventilation, progressing to apnea in overdose.

Medication guidance for opioids such as oxycodone warns that breathing problems are most likely in the first one to three days and after dose increases, and lists extreme drowsiness, unusual snoring and long pauses in breathing during sleep as serious effects. In a client with OSA those warnings overlap with their baseline problem, so small changes deserve attention.

Snoring is a warning sign, not reassurance

A sleeping client who snores looks comfortable, and a pain score cannot be obtained, so it is tempting to let them rest. Snoring is the sound of air forced through a partly closed airway. Combined with pauses, falling saturation or difficulty waking, it signals obstruction and excess sedation, which can progress to respiratory arrest if no one intervenes.

Assess sedation with the unit's scale before each opioid dose and when the client seems drowsy, alongside respiratory rate, depth, rhythm and saturation. Increasing sedation often appears before a dangerous fall in respiratory rate, so a client who drifts off mid-sentence needs action even if the numbers still look acceptable. Continuous oximetry or capnography may be part of local protocol for these clients.

First actions and escalation

Wake the client with voice and touch, sit them up or turn them onto their side to open the airway, and apply their own CPAP if it is prescribed. Give oxygen per protocol and recheck respiratory rate, sedation level and saturation. Withhold the next opioid or sedative dose and report the findings to the provider, who may change the analgesic plan toward non-opioid options.

If the client cannot be roused or breathing is slow, shallow or absent, call the rapid response team, support breathing and prepare naloxone according to the order. Naloxone reverses opioid-related respiratory depression quickly, but sedation can return as it wears off, especially with long-acting opioids. The client therefore needs continued observation after any reversal.

Prevention in the post-operative plan

The safest shift is one where the risk was planned for. Flag known or suspected sleep apnea at handover, confirm the client's CPAP is available and working, and raise any heavy reliance on opioids with the provider. Multimodal pain relief that reduces opioid need, careful timing of sedating medicines and avoiding unnecessary night-time sedatives all lower risk.

Teach the client and family that loud snoring, long pauses or being hard to wake after surgery are reasons to call the nurse, not signs of good rest. Ask assistive personnel to report the same observations. Their reports are valuable cues, but the registered nurse performs the sedation assessment and decides on the next opioid dose.

Prioritise a hypothetical post-operative question

Imagine a hypothetical client with OSA on the first night after knee surgery. A nursing assistant reports loud snoring with long pauses, saturation is low and the client groans but does not open their eyes. A PRN opioid is due. Options include giving the opioid while the client is settled, letting them sleep, asking the assistant to recheck in an hour, or rousing, repositioning and applying CPAP.

Rousing, repositioning and applying CPAP is the strongest answer, followed by sedation scoring and escalation. Giving the due opioid deepens sedation, letting the client sleep treats obstruction as rest, and delegating a recheck hands an unstable client to someone who cannot assess them. Routine vital signs on stable clients can be delegated once this client is safe.

Sources and further reading

MSD Manual Professional: Obstructive sleep apnea. Anaesthesia and sedation as risks for airway obstruction, perioperative CPAP, snoring and positional therapy.

MSD Manual Professional: Opioid toxicity and withdrawal. Opioid respiratory depression progressing to apnea, naloxone reversal and recurrence with long-acting opioids requiring observation.

MedlinePlus: Oxycodone. Breathing risk in the first 24 to 72 hours and after dose increases, extreme drowsiness, unusual snoring and pauses in breathing as serious effects.